Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Zimmer Biomet (ZBH), a leading musculoskeletal healthcare company, is identified as a strong momentum stock by Zacks, despite its #3 (Hold) Zacks Rank. The company holds an 'A' Momentum Style Score and a 'B' VGM Score, with shares appreciating 10.3% over the last four weeks. Notably, 10 analysts have revised their fiscal 2025 earnings estimates upwards in the past 60 days, raising the Zacks Consensus Estimate to $8.11 per share, suggesting positive sentiment and potential for momentum-focused investors.

Analysis

Zimmer Biomet (ZBH) exhibits strong momentum characteristics, evidenced by its 'A' Momentum Style Score from Zacks and a 10.3% share price increase over the past four weeks. This technical strength is underpinned by positive fundamental signals, most notably the upward revision of fiscal 2025 earnings estimates by 10 analysts within the last 60 days. This has lifted the Zacks Consensus Estimate by $0.16 to $8.11 per share. Furthermore, the company has a track record of beating earnings expectations, boasting an average surprise of +1.8%. However, these bullish indicators are contrasted by the stock's overall Zacks Rank of #3 (Hold), which suggests that while near-term momentum and earnings sentiment are favorable, the broader investment case may have moderating factors that prevent a 'Buy' rating from the system. The 'B' grade for the composite VGM Score indicates a generally positive but not top-tier profile across value, growth, and momentum metrics combined.

Key Decisions for Investors

• Given the 'A' Momentum Score and positive earnings estimate revisions, investors with a momentum-focused strategy should consider ZBH a candidate for their short list.
• The conflicting #3 (Hold) rank serves as a caution, suggesting investors should weigh the strong recent performance against a potentially more neutral long-term outlook or valuation.
• Monitor the trend in analyst earnings revisions for fiscal 2025, as continued upward adjustments are a key pillar supporting the current momentum thesis for the stock.